0 (0%) | 09-27 09:34 | |||||||||||||
|
|
Short term | ![]() ![]() ![]() |
|||
Mid term | ![]() |
|||
Targets | 6-month : | 115.12 | 1-year : | 134.47 |
Resists | First : | 98.56 | Second : | 115.12 |
Pivot price | 93.68 ![]() |
|||
Supports | First : | 91.18 | Second : | 86.62 |
MAs | MA(5) : | 95.35 ![]() |
MA(20) : | 93.41 ![]() |
MA(100) : | 96.88 ![]() |
MA(250) : | 95.95 ![]() |
|
MACD | MACD : | 0.8 ![]() |
Signal : | 0.4 ![]() |
%K %D | K(14,3) : | 69.3 ![]() |
D(3) : | 60 ![]() |
RSI | RSI(14): 57.6 ![]() |
|||
52-week | High : | 116.65 | Low : | 74.06 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ HQY ] has closed below upper band by 6.1%. Bollinger Bands are 44.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.
If tomorrow: | Open lower | Open higher |
High: | 97.49 - 97.86 | 97.86 - 98.24 |
Low: | 94.1 - 94.55 | 94.55 - 95 |
Close: | 95.8 - 96.49 | 96.49 - 97.18 |
Fri, 26 Sep 2025
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term - sharewise.com
Fri, 26 Sep 2025
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term - Yahoo Finance
Thu, 25 Sep 2025
90% of Bronze ACA Plans to Become HSA-Eligible: HealthEquity Strengthens Leadership for Market Expansion - Stock Titan
Wed, 24 Sep 2025
J.P. Morgan Maintains HealthEquity(HQY.US) With Buy Rating, Maintains Target Price $126 - 富途牛牛
Wed, 24 Sep 2025
Insiders At HealthEquity Sold US$20m In Stock, Alluding To Potential Weakness - simplywall.st
Tue, 23 Sep 2025
HealthEquity, Inc. $HQY Shares Purchased by Covea Finance - MarketBeat
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
|
|
Sector:
|
|
Industry:
|
|
Shares Out | 86 (M) |
Shares Float | 85 (M) |
Held by Insiders | 2.2 (%) |
Held by Institutions | 108.4 (%) |
Shares Short | 5,010 (K) |
Shares Short P.Month | 4,800 (K) |
EPS | 1.64 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 24.84 |
Profit Margin | 11.4 % |
Operating Margin | 27.8 % |
Return on Assets (ttm) | 4.9 % |
Return on Equity (ttm) | 6.7 % |
Qtrly Rev. Growth | 8.6 % |
Gross Profit (p.s.) | 9.78 |
Sales Per Share | 14.74 |
EBITDA (p.s.) | 4.99 |
Qtrly Earnings Growth | 70 % |
Operating Cash Flow | 367 (M) |
Levered Free Cash Flow | 288 (M) |
PE Ratio | 58.5 |
PEG Ratio | 0 |
Price to Book value | 3.88 |
Price to Sales | 6.54 |
Price to Cash Flow | 22.66 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |